durapatite has been researched along with Lung Adenocarcinoma in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, JC; Fang, HW; Lin, FH; Tang, TP; Tseng, CL; Wu, YC | 1 |
1 other study(ies) available for durapatite and Lung Adenocarcinoma
| Article | Year |
|---|---|
Development of lattice-inserted 5-Fluorouracil-hydroxyapatite nanoparticles as a chemotherapeutic delivery system.
Topics: 3T3 Cells; Adenocarcinoma; Adenocarcinoma of Lung; Animals; Antimetabolites, Antineoplastic; Cell Line, Tumor; Drug Carriers; Durapatite; Fluorouracil; Humans; Lung Neoplasms; Mice; Nanoparticles | 2015 |